G1 Therapeutics
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|
Revenue | $16,546 | $14,476 | $14,873 | $12,300 |
Gross Profit | 15,813 | 13,397 | 13,617 | 9,224 |
EBITDA | -3,414 | -8,928 | -8,805 | -16,368 |
EBIT | -3,535 | -9,048 | -8,929 | -16,495 |
Net Income | -5,469 | -10,219 | -10,878 | -18,204 |
Net Change In Cash | 16,546 | 14,476 | 14,873 | 12,300 |
Free Cash Flow | -5,274 | -8,898 | -12,792 | -10,577 |
Cash | 15,137 | 19,950 | 32,281 | 94,352 |
Basic Shares | 52,475 | 52,171 | 51,838 | 51,777 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $82,511 | $51,301 | $31,476 | $45,285 |
Gross Profit | 75,316 | 47,553 | 29,460 | 45,285 |
EBITDA | -39,014 | -134,897 | -142,760 | -96,066 |
EBIT | -39,527 | -135,427 | -143,229 | -96,648 |
Net Income | -47,967 | -147,559 | -148,352 | -99,254 |
Net Change In Cash | 82,511 | 51,301 | 31,476 | 45,285 |
Cost of Revenue | -126,654 | 13,755 | -61,902 | |
Free Cash Flow | -38,337 | -129,126 | -132,108 | -83,742 |
Cash | 32,281 | 94,594 | 221,186 | 207,306 |
Basic Shares | 51,733 | 43,626 | 41,943 | 37,878 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | -$0.10 |
2024-03-31 | -$0.20 |
2023-12-31 | -$0.21 |
2023-09-30 | -$0.35 |
